Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1996 Jul;9(3):335–348. doi: 10.1128/cmr.9.3.335

Immunopathogenesis of recurrent vulvovaginal candidiasis.

P L Fidel Jr 1, J D Sobel 1
PMCID: PMC172897  PMID: 8809464

Abstract

Recurrent vulvovaginal candidiasis (RVVC) is a prevalent opportunistic mucosal infection, caused predominantly by Candida albicans, which affects a significant number of otherwise healthy women of childbearing age. Since there are no known exogenous predisposing factors to explain the incidence of symptomatic vaginitis in most women with idiopathic RVVC, it has been postulated that these particular women suffer from an immunological abnormality that prediposes them to RVVC. Because of the increased incidence of mucosal candidiasis in individuals with depressed cell-mediated immunity (CMI), defects in CMI are viewed as a possible explanation for RVVC. In this review, we attempt to place into perspective the accumulated information regarding the immunopathogenesis of RVVC, as well as to provide new immunological perspectives and hypotheses regarding potential immunological deficiencies that may predispose to RVVC and potentially other mucosal infections by the same organism. The results of both clinical studies and studies in an animal model of experimental vaginitis suggest that systemic CMI may not be the predominant host defense mechanism against C. albicans vaginal infections. Rather, locally acquired mucosal immunity, distinct from that in the peripheral circulation, is now under consideration as an important host defense at the vaginal mucosa, as well as the notion that changes in local CMI mechanism(s) may predispose to RVVC.

Full Text

The Full Text of this article is available as a PDF (353.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balish E., Filutowicz H., Oberley T. D. Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infect Immun. 1990 Jan;58(1):107–113. doi: 10.1128/iai.58.1.107-113.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brenner M. B., Strominger J. L., Krangel M. S. The gamma delta T cell receptor. Adv Immunol. 1988;43:133–192. [PubMed] [Google Scholar]
  3. Cain T. K., Rank R. G. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun. 1995 May;63(5):1784–1789. doi: 10.1128/iai.63.5.1784-1789.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cantorna M. T., Balish E. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect Immun. 1990 Apr;58(4):1093–1100. doi: 10.1128/iai.58.4.1093-1100.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cantorna M., Mook D., Balish E. Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidiasis. Infect Immun. 1990 Nov;58(11):3813–3815. doi: 10.1128/iai.58.11.3813-3815.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carlsten H., Holmdahl R., Tarkowski A. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice. Immunology. 1991 Jun;73(2):186–190. [PMC free article] [PubMed] [Google Scholar]
  7. Cassone A., De Bernardis F., Mondello F., Ceddia T., Agatensi L. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J Infect Dis. 1987 Nov;156(5):777–783. doi: 10.1093/infdis/156.5.777. [DOI] [PubMed] [Google Scholar]
  8. Clerici M., Shearer G. M. A TH1-->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1993 Mar;14(3):107–111. doi: 10.1016/0167-5699(93)90208-3. [DOI] [PubMed] [Google Scholar]
  9. Clift R. A. Candidiasis in the transplant patient. Am J Med. 1984 Oct 30;77(4D):34–38. [PubMed] [Google Scholar]
  10. Dabrowa N., Howard D. H. Heat shock and heat stroke proteins observed during germination of the blastoconidia of Candida albicans. Infect Immun. 1984 May;44(2):537–539. doi: 10.1128/iai.44.2.537-539.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Daynes R. A., Araneo B. A. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol. 1989 Dec;19(12):2319–2325. doi: 10.1002/eji.1830191221. [DOI] [PubMed] [Google Scholar]
  12. Daynes R. A., Dudley D. J., Araneo B. A. Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol. 1990 Apr;20(4):793–802. doi: 10.1002/eji.1830200413. [DOI] [PubMed] [Google Scholar]
  13. De Bernardis F., Agatensi L., Ross I. K., Emerson G. W., Lorenzini R., Sullivan P. A., Cassone A. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. J Infect Dis. 1990 Jun;161(6):1276–1283. doi: 10.1093/infdis/161.6.1276. [DOI] [PubMed] [Google Scholar]
  14. De Bernardis F., Cassone A., Sturtevant J., Calderone R. Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis. Infect Immun. 1995 May;63(5):1887–1892. doi: 10.1128/iai.63.5.1887-1892.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. De Bernardis F., Molinari A., Boccanera M., Stringaro A., Robert R., Senet J. M., Arancia G., Cassone A. Modulation of cell surface-associated mannoprotein antigen expression in experimental candidal vaginitis. Infect Immun. 1994 Feb;62(2):509–519. doi: 10.1128/iai.62.2.509-519.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ehrensaft D. V., Epstein R. B., Sarpel S., Andersen B. R. Disseminated candidiasis in leukopenic dogs. Proc Soc Exp Biol Med. 1979 Jan;160(1):6–10. doi: 10.3181/00379727-160-40377. [DOI] [PubMed] [Google Scholar]
  17. Elin R. J., Edelin J. B., Wolff S. M. Infection and immunoglobulin concentrations in Chediak-Higashi mice. Infect Immun. 1974 Jul;10(1):88–91. doi: 10.1128/iai.10.1.88-91.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ferrante A., Thong Y. H. Requirement of heat-labile opsonins for maximal phagocytosis of Candida albicans. Sabouraudia. 1979 Sep;17(3):293–297. doi: 10.1080/00362177985380431. [DOI] [PubMed] [Google Scholar]
  19. Fidel P. L., Jr, Lynch M. E., Conaway D. H., Tait L., Sobel J. D. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity. Infect Immun. 1995 Feb;63(2):547–553. doi: 10.1128/iai.63.2.547-553.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Fidel P. L., Jr, Lynch M. E., Redondo-Lopez V., Sobel J. D., Robinson R. Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis. J Infect Dis. 1993 Dec;168(6):1458–1465. doi: 10.1093/infdis/168.6.1458. [DOI] [PubMed] [Google Scholar]
  21. Fidel P. L., Jr, Lynch M. E., Sobel J. D. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis. Infect Immun. 1993 Oct;61(10):4202–4207. doi: 10.1128/iai.61.10.4202-4207.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Fidel P. L., Jr, Lynch M. E., Sobel J. D. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect Immun. 1993 May;61(5):1990–1995. doi: 10.1128/iai.61.5.1990-1995.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Fidel P. L., Jr, Lynch M. E., Sobel J. D. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect Immun. 1995 Jul;63(7):2403–2408. doi: 10.1128/iai.63.7.2403-2408.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Fidel P. L., Jr, Lynch M. E., Sobel J. D. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis. Infect Immun. 1994 Mar;62(3):1032–1038. doi: 10.1128/iai.62.3.1032-1038.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Fiorentino D. F., Zlotnik A., Vieira P., Mosmann T. R., Howard M., Moore K. W., O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 1991 May 15;146(10):3444–3451. [PubMed] [Google Scholar]
  26. Fischer A., Ballet J. J., Griscelli C. Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis. J Clin Invest. 1978 Nov;62(5):1005–1013. doi: 10.1172/JCI109204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Fleury F. J. Adult vaginitis. Clin Obstet Gynecol. 1981 Jun;24(2):407–438. doi: 10.1097/00003081-198106000-00008. [DOI] [PubMed] [Google Scholar]
  28. Fong I. W., Bannatyne R. M., Wong P. Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis. Genitourin Med. 1993 Feb;69(1):44–46. doi: 10.1136/sti.69.1.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Fong I. W., McCleary P., Read S. Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis. Am J Obstet Gynecol. 1992 Mar;166(3):887–890. doi: 10.1016/0002-9378(92)91356-f. [DOI] [PubMed] [Google Scholar]
  30. Frazier-Jessen M. R., Kovacs E. J. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J Immunol. 1995 Feb 15;154(4):1838–1845. [PubMed] [Google Scholar]
  31. Gajewski T. F., Joyce J., Fitch F. W. Antiproliferative effect of IFN-gamma in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma. J Immunol. 1989 Jul 1;143(1):15–22. [PubMed] [Google Scholar]
  32. Hobbs J. R., Brigden D., Davidson F., Kahan M., Oates J. K. Immunological aspects of candidal vaginitis. Proc R Soc Med. 1977;70 (Suppl 4):11–14. [PMC free article] [PubMed] [Google Scholar]
  33. Hocini H., Barra A., Bélec L., Iscaki S., Preud'homme J. L., Pillot J., Bouvet J. P. Systemic and secretory humoral immunity in the normal human vaginal tract. Scand J Immunol. 1995 Aug;42(2):269–274. doi: 10.1111/j.1365-3083.1995.tb03653.x. [DOI] [PubMed] [Google Scholar]
  34. Holm H. W., Marwin R. M. Effects of surface active agents on the susceptibility of Swiss mice to Candida albicans. Mycopathol Mycol Appl. 1967 Nov 13;33(2):186–192. doi: 10.1007/BF02053450. [DOI] [PubMed] [Google Scholar]
  35. Hurley R. Candidal vaginitis. Proc R Soc Med. 1977;70 (Suppl 4):1–2. [PMC free article] [PubMed] [Google Scholar]
  36. Hurley R., De Louvois J. Candida vaginitis. Postgrad Med J. 1979 Sep;55(647):645–647. doi: 10.1136/pgmj.55.647.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Hurley R. Recurrent Candida infection. Clin Obstet Gynaecol. 1981 Apr;8(1):209–214. [PubMed] [Google Scholar]
  38. Igietseme J. U., Rank R. G. Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigen-specific T cells in the genital tract. Infect Immun. 1991 Apr;59(4):1346–1351. doi: 10.1128/iai.59.4.1346-1351.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Itohara S., Farr A. G., Lafaille J. J., Bonneville M., Takagaki Y., Haas W., Tonegawa S. Homing of a gamma delta thymocyte subset with homogeneous T-cell receptors to mucosal epithelia. Nature. 1990 Feb 22;343(6260):754–757. doi: 10.1038/343754a0. [DOI] [PubMed] [Google Scholar]
  40. Kagaya K., Fukazawa Y. Murine defense mechanism against Candida albicans infection. II. Opsonization, phagocytosis, and intracellular killing of C. albicans. Microbiol Immunol. 1981;25(8):807–818. doi: 10.1111/j.1348-0421.1981.tb00084.x. [DOI] [PubMed] [Google Scholar]
  41. Kalo-Klein A., Witkin S. S. Prostaglandin E2 enhances and gamma interferon inhibits germ tube formation in Candida albicans. Infect Immun. 1990 Jan;58(1):260–262. doi: 10.1128/iai.58.1.260-262.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Kalo-Klein A., Witkin S. S. Regulation of the immune response to Candida albicans by monocytes and progesterone. Am J Obstet Gynecol. 1991 May;164(5 Pt 1):1351–1354. doi: 10.1016/0002-9378(91)90712-z. [DOI] [PubMed] [Google Scholar]
  43. Kaufmann S. H. Heat shock proteins and the immune response. Immunol Today. 1990 Apr;11(4):129–136. doi: 10.1016/0167-5699(90)90050-j. [DOI] [PubMed] [Google Scholar]
  44. Kent H. L. Epidemiology of vaginitis. Am J Obstet Gynecol. 1991 Oct;165(4 Pt 2):1168–1176. doi: 10.1016/s0002-9378(12)90722-x. [DOI] [PubMed] [Google Scholar]
  45. Kinsman O. S., Collard A. E. Hormonal factors in vaginal candidiasis in rats. Infect Immun. 1986 Sep;53(3):498–504. doi: 10.1128/iai.53.3.498-504.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Kirkpatrick C. H. Chronic mucocutaneous candidiasis. Eur J Clin Microbiol Infect Dis. 1989 May;8(5):448–456. doi: 10.1007/BF01964059. [DOI] [PubMed] [Google Scholar]
  47. Kirkpatrick C. H., Rich R. R., Bennett J. E. Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med. 1971 Jun;74(6):955–978. doi: 10.7326/0003-4819-74-6-955. [DOI] [PubMed] [Google Scholar]
  48. Klein R. S., Harris C. A., Small C. B., Moll B., Lesser M., Friedland G. H. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med. 1984 Aug 9;311(6):354–358. doi: 10.1056/NEJM198408093110602. [DOI] [PubMed] [Google Scholar]
  49. Klink M., Rózalska B., Rudnicka W. Osłabienie odpowiedzi komŕkowej na antygeny Listeria u myszy ciezarnych. Med Dosw Mikrobiol. 1993;45(1):51–54. [PubMed] [Google Scholar]
  50. Knight L., Fletcher J. Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids, and diabetes mellitus. J Infect Dis. 1971 Apr;123(4):371–377. doi: 10.1093/infdis/123.4.371. [DOI] [PubMed] [Google Scholar]
  51. Liljemark W. F., Gibbons R. J. Suppression of Candida albicans by human oral streptococci in gnotobiotic mice. Infect Immun. 1973 Nov;8(5):846–849. doi: 10.1128/iai.8.5.846-849.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Macher A. M. The pathology of AIDS. Public Health Rep. 1988 May-Jun;103(3):246–254. [PMC free article] [PubMed] [Google Scholar]
  53. Maggi E., Mazzetti M., Ravina A., Annunziato F., de Carli M., Piccinni M. P., Manetti R., Carbonari M., Pesce A. M., del Prete G. Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science. 1994 Jul 8;265(5169):244–248. doi: 10.1126/science.8023142. [DOI] [PubMed] [Google Scholar]
  54. Mathur S., Koistinen G. V., Horger E. O., 3rd, Mahvi T. A., Fudenberg H. H. Humoral immunity in vaginal candidiasis. Infect Immun. 1977 Jan;15(1):287–294. doi: 10.1128/iai.15.1.287-294.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Matthews R. C., Burnie J. P., Howat D., Rowland T., Walton F. Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology. 1991 Sep;74(1):20–24. [PMC free article] [PubMed] [Google Scholar]
  56. Matthews R. C., Burnie J. P., Tabaqchali S. Immunoblot analysis of the serological response in systemic candidosis. Lancet. 1984 Dec 22;2(8417-8418):1415–1418. doi: 10.1016/s0140-6736(84)91618-0. [DOI] [PubMed] [Google Scholar]
  57. Matthews R. C., Burnie J. P., Tabaqchali S. Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J Clin Microbiol. 1987 Feb;25(2):230–237. doi: 10.1128/jcm.25.2.230-237.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Matthews R., Burnie J. The role of hsp90 in fungal infection. Immunol Today. 1992 Sep;13(9):345–348. doi: 10.1016/0167-5699(92)90169-8. [DOI] [PubMed] [Google Scholar]
  59. Mazumder D. N., Ghose N., Mitra J., Dutta G., Santra A. Immunological status of women with prolonged oral contraceptives and occurrence of giardiasis. J Indian Med Assoc. 1990 May;88(5):129–131. [PubMed] [Google Scholar]
  60. Morris H., Emms M., Visser T., Timme A. Lymphoid tissue of the normal fallopian tube--a form of mucosal-associated lymphoid tissue (MALT)? Int J Gynecol Pathol. 1986;5(1):11–22. doi: 10.1097/00004347-198603000-00002. [DOI] [PubMed] [Google Scholar]
  61. Morton R. S., Rashid S. Candidal vaginitis: natural history, predisposing factors and prevention. Proc R Soc Med. 1977;70 (Suppl 4):3–6. [PMC free article] [PubMed] [Google Scholar]
  62. Mosmann T. R., Coffman R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145–173. doi: 10.1146/annurev.iy.07.040189.001045. [DOI] [PubMed] [Google Scholar]
  63. Nandi D., Allison J. P. Phenotypic analysis and gamma delta-T cell receptor repertoire of murine T cells associated with the vaginal epithelium. J Immunol. 1991 Sep 15;147(6):1773–1778. [PubMed] [Google Scholar]
  64. Nohmi T., Abe S., Dobashi K., Tansho S., Yamaguchi H. Suppression of anti-Candida activity of murine neutrophils by progesterone in vitro: a possible mechanism in pregnant women's vulnerability to vaginal candidiasis. Microbiol Immunol. 1995;39(6):405–409. doi: 10.1111/j.1348-0421.1995.tb02220.x. [DOI] [PubMed] [Google Scholar]
  65. Parr M. B., Kepple L., Parr E. L. Antigen recognition in the female reproductive tract. II. Endocytosis of horseradish peroxidase by Langerhans cells in murine vaginal epithelium. Biol Reprod. 1991 Aug;45(2):261–265. doi: 10.1095/biolreprod45.2.261. [DOI] [PubMed] [Google Scholar]
  66. Parr M. B., Kepple L., Parr E. L. Langerhans cells phagocytose vaginal epithelial cells undergoing apoptosis during the murine estrous cycle. Biol Reprod. 1991 Aug;45(2):252–260. doi: 10.1095/biolreprod45.2.252. [DOI] [PubMed] [Google Scholar]
  67. Parr M. B., Parr E. L. Antigen recognition in the female reproductive tract: I. Uptake of intraluminal protein tracers in the mouse vagina. J Reprod Immunol. 1990 Apr;17(2):101–114. doi: 10.1016/0165-0378(90)90029-6. [DOI] [PubMed] [Google Scholar]
  68. Parr M. B., Parr E. L. Langerhans cells and T lymphocyte subsets in the murine vagina and cervix. Biol Reprod. 1991 Mar;44(3):491–498. doi: 10.1095/biolreprod44.3.491. [DOI] [PubMed] [Google Scholar]
  69. Paterson P. Y., Semo R., Blumenschein G., Swelstad J. Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy. Clin Exp Immunol. 1971 Nov;9(5):595–602. [PMC free article] [PubMed] [Google Scholar]
  70. Polonelli L., De Bernardis F., Conti S., Boccanera M., Gerloni M., Morace G., Magliani W., Chezzi C., Cassone A. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies. J Immunol. 1994 Mar 15;152(6):3175–3182. [PubMed] [Google Scholar]
  71. Puccetti P., Romani L., Bistoni F. A TH1-TH2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol. 1995 Jun;3(6):237–240. doi: 10.1016/s0966-842x(00)88931-3. [DOI] [PubMed] [Google Scholar]
  72. Regúlez P., García Fernández J. F., Moragues M. D., Schneider J., Quindós G., Pontón J. Detection of anti-Candida albicans IgE antibodies in vaginal washes from patients with acute vulvovaginal candidiasis. Gynecol Obstet Invest. 1994;37(2):110–114. doi: 10.1159/000292536. [DOI] [PubMed] [Google Scholar]
  73. Rigg D., Miller M. M., Metzger W. J. Recurrent allergic vulvovaginitis: treatment with Candida albicans allergen immunotherapy. Am J Obstet Gynecol. 1990 Feb;162(2):332–336. doi: 10.1016/0002-9378(90)90380-p. [DOI] [PubMed] [Google Scholar]
  74. Rogers T. J., Balish E. Immunity to Candida albicans. Microbiol Rev. 1980 Dec;44(4):660–682. doi: 10.1128/mr.44.4.660-682.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Romani L., Mencacci A., Cenci E., Spaccapelo R., Mosci P., Puccetti P., Bistoni F. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J Immunol. 1993 Feb 1;150(3):925–931. [PubMed] [Google Scholar]
  76. Romani L., Mocci S., Bietta C., Lanfaloni L., Puccetti P., Bistoni F. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect Immun. 1991 Dec;59(12):4647–4654. doi: 10.1128/iai.59.12.4647-4654.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Rosedale N., Browne K. Hyposensitisation in the management of recurring vaginal candidiasis. Ann Allergy. 1979 Oct;43(4):250–253. [PubMed] [Google Scholar]
  78. Ross I. K., De Bernardis F., Emerson G. W., Cassone A., Sullivan P. A. The secreted aspartate proteinase of Candida albicans: physiology of secretion and virulence of a proteinase-deficient mutant. J Gen Microbiol. 1990 Apr;136(4):687–694. doi: 10.1099/00221287-136-4-687. [DOI] [PubMed] [Google Scholar]
  79. Ryley J. F., McGregor S. Quantification of vaginal Candida albicans infections in rodents. J Med Vet Mycol. 1986 Dec;24(6):455–460. [PubMed] [Google Scholar]
  80. Schröppel K., Rotman M., Galask R., Mac K., Soll D. R. Evolution and replacement of Candida albicans strains during recurrent vaginitis demonstrated by DNA fingerprinting. J Clin Microbiol. 1994 Nov;32(11):2646–2654. doi: 10.1128/jcm.32.11.2646-2654.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Sobel J. D., Muller G., Buckley H. R. Critical role of germ tube formation in the pathogenesis of candidal vaginitis. Infect Immun. 1984 Jun;44(3):576–580. doi: 10.1128/iai.44.3.576-580.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Sobel J. D., Muller G., McCormick J. F. Experimental chronic vaginal candidosis in rats. Sabouraudia. 1985 Jun;23(3):199–206. doi: 10.1080/00362178585380301. [DOI] [PubMed] [Google Scholar]
  83. Sobel J. D., Myers P. G., Kaye D., Levison M. E. Adherence of Candida albicans to human vaginal and buccal epithelial cells. J Infect Dis. 1981 Jan;143(1):76–82. doi: 10.1093/infdis/143.1.76. [DOI] [PubMed] [Google Scholar]
  84. Sobel J. D. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann N Y Acad Sci. 1988;544:547–557. doi: 10.1111/j.1749-6632.1988.tb40450.x. [DOI] [PubMed] [Google Scholar]
  85. Sobel J. D. Vaginal infections in adult women. Med Clin North Am. 1990 Nov;74(6):1573–1602. doi: 10.1016/s0025-7125(16)30496-5. [DOI] [PubMed] [Google Scholar]
  86. Soll D. R., Galask R., Isley S., Rao T. V., Stone D., Hicks J., Schmid J., Mac K., Hanna C. Switching of Candida albicans during successive episodes of recurrent vaginitis. J Clin Microbiol. 1989 Apr;27(4):681–690. doi: 10.1128/jcm.27.4.681-690.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Soll D. R. High-frequency switching in Candida albicans and its relations to vaginal candidiasis. Am J Obstet Gynecol. 1988 Apr;158(4):997–1001. doi: 10.1016/0002-9378(88)90113-5. [DOI] [PubMed] [Google Scholar]
  88. Soll D. R. High-frequency switching in Candida albicans. Clin Microbiol Rev. 1992 Apr;5(2):183–203. doi: 10.1128/cmr.5.2.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Styrt B., Sugarman B. Estrogens and infection. Rev Infect Dis. 1991 Nov-Dec;13(6):1139–1150. doi: 10.1093/clinids/13.6.1139. [DOI] [PubMed] [Google Scholar]
  90. Syverson R. E., Buckley H., Gibian J., Ryan G. M., Jr Cellular and humoral immune status in women with chronic Candida vaginitis. Am J Obstet Gynecol. 1979 Jul 15;134(6):624–627. doi: 10.1016/0002-9378(79)90641-0. [DOI] [PubMed] [Google Scholar]
  91. Thapar M. A., Parr E. L., Bozzola J. J., Parr M. B. Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM). Vaccine. 1991 Feb;9(2):129–133. doi: 10.1016/0264-410x(91)90269-c. [DOI] [PubMed] [Google Scholar]
  92. Thapar M. A., Parr E. L., Parr M. B. Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization. Immunology. 1990 May;70(1):121–125. [PMC free article] [PubMed] [Google Scholar]
  93. Trumbore D. J., Sobel J. D. Recurrent vulvovaginal candidiasis: vaginal epithelial cell susceptibility to Candida albicans adherence. Obstet Gynecol. 1986 Jun;67(6):810–812. [PubMed] [Google Scholar]
  94. Uehling D. T., James L. J., Hopkins W. J., Balish E. Immunization against urinary tract infection with a multi-valent vaginal vaccine. J Urol. 1991 Jul;146(1):223–226. doi: 10.1016/s0022-5347(17)37756-x. [DOI] [PubMed] [Google Scholar]
  95. Vazquez J. A., Sobel J. D., Demitriou R., Vaishampayan J., Lynch M., Zervos M. J. Karyotyping of Candida albicans isolates obtained longitudinally in women with recurrent vulvovaginal candidiasis. J Infect Dis. 1994 Dec;170(6):1566–1569. doi: 10.1093/infdis/170.6.1566. [DOI] [PubMed] [Google Scholar]
  96. Wira C. R., Rossoll R. M. Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina. Immunology. 1995 Apr;84(4):505–508. [PMC free article] [PubMed] [Google Scholar]
  97. Witkin S. S., Hirsch J., Ledger W. J. A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am J Obstet Gynecol. 1986 Oct;155(4):790–795. doi: 10.1016/s0002-9378(86)80022-9. [DOI] [PubMed] [Google Scholar]
  98. Witkin S. S. Immunologic factors influencing susceptibility to recurrent candidal vaginitis. Clin Obstet Gynecol. 1991 Sep;34(3):662–668. [PubMed] [Google Scholar]
  99. Witkin S. S., Jeremias J., Ledger W. J. A localized vaginal allergic response in women with recurrent vaginitis. J Allergy Clin Immunol. 1988 Feb;81(2):412–416. doi: 10.1016/0091-6749(88)90909-8. [DOI] [PubMed] [Google Scholar]
  100. Witkin S. S., Jeremias J., Ledger W. J. Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis. J Med Vet Mycol. 1989;27(1):57–58. [PubMed] [Google Scholar]
  101. Witkin S. S., Kalo-Klein A., Galland L., Teich M., Ledger W. J. Effect of Candida albicans plus histamine on prostaglandin E2 production by peripheral blood mononuclear cells from healthy women and women with recurrent candidal vaginitis. J Infect Dis. 1991 Aug;164(2):396–399. doi: 10.1093/infdis/164.2.396. [DOI] [PubMed] [Google Scholar]
  102. Witkin S. S., Yu I. R., Ledger W. J. Inhibition of Candida albicans--induced lymphocyte proliferation by lymphocytes and sera from women with recurrent vaginitis. Am J Obstet Gynecol. 1983 Dec 1;147(7):809–811. doi: 10.1016/0002-9378(83)90044-3. [DOI] [PubMed] [Google Scholar]
  103. Wu H. Y., Russell M. W. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun. 1993 Jan;61(1):314–322. doi: 10.1128/iai.61.1.314-322.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Yamamura M., Valdimarsson H. Participation of C3 in intracellular killing of Candida albicans. Scand J Immunol. 1977;6(6-7):591–594. doi: 10.1111/j.1365-3083.1977.tb02137.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES